Abstract
Movement disorders (MDs) in children have some peculiarities compared with adults. In front of a pediatric patient with a specific type of movement disorder, usually the etiologies are different from those considered in an adult, and by the other hand, the clinical manifestations are different because they are influenced by the age of onset of a certain disease. In children with movement disorders, hyperkinetic movements predominate; in adults bradykinesia is much more prevalent. Moreover, certain disorders occur almost exclusively in children, as is the case of transient movement disorders, or are much more frequent as metabolic and autoimmune diseases.
Keywords
- Systemic Lupus Erythematosus
- Movement Disorder
- Essential Tremor
- Stiff Person Syndrome
- Methylmalonic Acidemia
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Fernandez-Alvarez E. Transient movement disorders in children. J Neurol. 1998;245:1.
Shuper A, Zalzberg J, Weitz R, Mimouni M. Jitteriness beyond the neonatal period: a benign pattern of movement in infancy. J Child Neurol. 1991;6(3):243–5.
Kaddurah AK, Holmes GL. Benign neonatal sleep myoclonus: history and semiology. Pediatr Neurol. 2009;40:343–6.
Maurer VO, Rizzi M, Bianchetti MG, Ramelli GP. Benign neonatal sleep myoclonus: a review of the literature. Pediatrics. 2010;125(4):e919–24.
Caraballo RH, Capovilla G, Vigevano F, Beccaria F, Specchio N, Fejerman N. The spectrum of benign myoclonus of early infancy: clinical and neurophysiologic features in 102 patients. Epilepsia. 2009;50(5):1176–83.
Bonnet C, Roubertie A, Doummar D, Bahi-Buisson N, Cock VC, Roze E. Developmental and benign movement disorders in childhood. Mov Disord. 2010;25(10):1317–34.
Gottlob I, Wizov SS, Reinecke RD. Spasmus nutans. A long-term follow-up. Invest Ophthalmol Vis Sci. 1995;36(13):2768–71.
Wizov SS, Reinecke RD, Bocarnea M, Gottlob I. A comparative demographic and socioeconomic study of spasmus nutans and infantile nystagmus. Am J Ophthalmol. 2002;133:256–62.
Drigo P, Carli G, Laverda AM. Benign paroxysmal torticollis of infancy. Brain Dev. 2000;22(3):169–72.
Giffin NJ, Benton S, Goadsby PJ. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol. 2002;44(7):490–3.
Campistol J, Prats JM, Garaizar C. Benign paroxysmal tonic upgaze in childhood with ataxia: a neuro-ophthalmological syndrome of familial origin? Dev Med Child Neurol. 1993;35:436–9.
Ouvrier R, Billson F. Paroxysmal tonic upgaze of childhood-a review. Brain Dev. 2005;27(3):185–8.
Good WV, Hou C, Carden SM. Transient, idiopathic nystagmus in infants. Dev Med Child Neurol. 2003;45:304–7.
Calado R, Monteiro JP, Fonseca MJ. Transient idiopathic dystonia in infancy. Acta Paediatr. 2011;100(4):624–7.
Vanasse M, Bedard P, Andermann F. Shuddering attacks in children: an early clinical manifestation of essential tremor. Neurology. 1976;26:1027–30.
Fernandez-Alvarez E, Aicardi J, Bathien N. Movement disorders in children. New York: Cambridge University Press; 2001.
Pons R. The phenotypic spectrum of paediatric neurotransmitter diseases and infantile parkinsonism. J Inherit Metab Dis. 2009;32:321–32.
Kurian MA, Zhen J, Cheng SY, Li Y, Mordekar SR, Jardine P, Morgan NV, Meyer E, Tee L, et al. Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J Clin Invest. 2009;119(6):1595–603.
Garcia Cazorla A, Rabier D, Touati G, Chadefaux-Vekemans B, Marsac C, de Lonlay P, Saudubray JM. Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects. Ann Neurol. 2006;59:121–12.
Assmann B, Surtees R, Hoffmann GF. Approach to the diagnosis of neurotransmitter diseases exemplified by the differential diagnosis of childhood-onset dystonia. Ann Neurol. 2003;54 Suppl 6:S18–24.
Garcia-Cazorla A, Wolf NI, Serrano M, Perez-Duenas B, Pineda M, Campistol J, et al. Inborn errors of metabolism and motor disturbances in children. J Inherit Metab Dis. 2009;32:618–29.
Temudo T, Martins E, Poças F, Cruz R, Vilarinho L. Maple syrup disease presenting as paroxysmal dystonia. Ann Neurol. 2004;56(5):749–50.
Suls A, Dedeken P, Goffin K, Van Esch H, Dupont P, Cassiman D, et al. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain. 2008;131(Pt 7):1831–44.
Sedel F, Saudubray J-M, Roze E, Agid Y, Vidailhet M. Movement disorders and inborn errors of metabolism in adults: a diagnostic approach. J Inherit Metab Dis. 2008;31:308–18.
Gouider-Khouja N, Kraoua I, Benrrhouma H, Fraj N, Rouiissi A. Movement disorders in neuro-metabolic diseases. Eur J Paediatr Neurol. 2010;14:304–7.
Ozand PT, Gascon GG, Al Essa M, Joshi S, Al Jishi E, Bakheet S, et al. Biotin-responsive basal ganglia disease: a novel entity. Brain. 1998;121(Pt 7):1267–79.
Demiroren K, Yavuz H, Cam L, Oran B, Karaaslan S, Demiroren S. Sydenham’s chorea: a clinical follow-up of 65 patients. J Child Neurol. 2007;22:550–4.
Cardoso F, Silva CE, Mota CC. Sydenham’s chorea in 50 consecutive patients with rheumatic fever. Mov Disord. 1997;12:701–3.
Paz JA, Silva CAA, Marques-Dias MJ. Randomized double-blind study with prednisone in Sydenham’s chorea. Pediatr Neurol. 2006;34:264–9.
Swedo SE. Sydenham’s chorea. A model for childhood autoimmune neuropsychiatric disorders. JAMA. 1994;272:1788–91.
Baizabal-Carvallo JF M.D., M.Sc., Jankovic J M.D. Movement disorders in autoimmune diseases. Mov Disord. 2012;27(8):935.
Garvey MA, Swedo SE. Sydenham’s chorea clinical and therapeutic update. Adv Exp Med Biol. 1997;418(2):115–20.
BaizabalCarvallo JF, Alonso-Juarez M, Koslowski M. Chorea in systemic lupus erythematosus. J Clin Rheumatol. 2011;17:69–72.
Cervera R, Asherson RA, Font J, et al. Chorea in the antiphospholipid syndrome: clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore). 1997;76:203–12.
Angelini L, Zibordi F, Zorzi G, et al. Neurological disorders, other than stroke, associated with antiphospholipid antibodies in childhood. Neuropediatrics. 1996;27:149.
Kiechl-Kohlendorfer U, Ellemunter H, Kiechl S. Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood. Neuropediatrics. 1999;30:96.
Watanabe T, Onda H. Hemichorea with antiphospholipid antibodies in a patient with lupus nephritis. Pediatr Nephrol. 2004;19:451.
Avcin T, Cimaz R, Meroni PL. Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus. 2002;11:4.
Ravelli A, Martini A. Antiphospholipid syndrome. Pediatr Clin North Am. 2005;52:469.
Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63–74.
Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–33.
Kieslich M, Errázuriz G, Posselt HG, et al. Brain white-matter lesions in celiac disease: a prospective study of 75 diet-treated patients. Pediatrics. 2001;108:E21.
Zelnik N, Pacht A, Obeid R, et al. Range of neurologic disorders in patients with celiac disease. Pediatrics. 2004;113:1672–6.
Dale RC, Merheb V, Pillai S, Wang D, Cantrill L, Murphy TK, Ben-Pazi H, Varadkar S, Aumann TD, Horne MK, Church AJ, Fath T, Brilot F. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain. 2012;135:3453–68.
Zomorrodi A, Wald ER. Sydenham’s chorea in western Pennsylvania. Pediatrics. 2006;117:e675–9.
Walker KG, Lawrenson J, Wilmshurst JM. Neuropsychiatric movement disorders following streptococcal infection. Dev Med Child Neurol. 2005;47:771–5.
Walker KG, Wilmshurst JM. An update on the treatment of Sydenham’s chorea: the evidence for established and evolving interventions. Ther Adv Neurol Disord. 2010;3(5):301–9.
Cardoso F. Sydenham’s chorea. Curr Treat Options Neurol. 2008;10:230–5.
Garvey MA, Snider LA, Leitman SF, Werden R, Swedo SE. Treatment of Sydenham’s chorea with intravenous immunoglobulin, plasma exchange, or prednisone. J Child Neurol. 2005;20:424–9.
Dalmau J, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091–8.
Ferdinand P, Mitchell L. AntiNMDA receptor encephalitis. J Clin Cell Immunol. 2012;S10:007. doi:10.4172/2155-9899.S10-007.
Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain. 2010;133:1655–67.
Krug P, Schleiermacher G, Michon J, et al. Opsoclonus-myoclonus in children associated or not with neuroblastoma. Eur J Paediatr Neurol. 2010;14:400–9.
Tate ED, Allison TJ, Pranzatelli MR, et al. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome. J Pediatr Oncol Nurs. 2005;22:8–19.
Blaes F. Paraneoplastic brain stem encephalitis. Curr Treat Options Neurol. 2013;15:201–9.
Turner MR, Irani SR, Leite MI, Nithi K, Vincent A, Ansorge O. Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies. Neurology. 2011;77(5):439–43.
Damásio J, Leite MI, Coutinho E, Waters P, Woodhall M, Santos MA, Carrilho I, Vincent A. Progressive encephalomyelitis with rigidity and myoclonus: the first pediatric case with glycine receptor antibodies. JAMA Neurol. 2013;70(4):498–501.
Swedo SE, Leonard HL, Mittleman BB, et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatr. 1997;154:110–2.
Mamoudjy N, Korff C, Maurey H, Blanchard G, Steshenko D, Loiseau-Corvez M-N, Husson B, Brauner R, Tardieu M, Deiva K. Hashimoto’s encephalopathy: identification and long-term outcome in children. Eur J Paediatr Neurol. 2013;17:280e287.
Erol I, Saygi S, Alehan F. Hashimoto’s encephalopathy in children and adolescents. Pediatr Neurol. 2011;45:420e2.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Wien
About this chapter
Cite this chapter
Temudo, T., Carrilho, I. (2017). Movement Disorders in Children. In: Falup-Pecurariu, C., Ferreira, J., Martinez-Martin, P., Chaudhuri, K. (eds) Movement Disorders Curricula. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1628-9_42
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1628-9_42
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1627-2
Online ISBN: 978-3-7091-1628-9
eBook Packages: MedicineMedicine (R0)